2021-04-19 |
2021-04-16 |
S
Sale
|
Chereau Frederic
President and Chief Executive
Executive Director
|
7,542
-2.9%
5.73
USD 43,216
|
7,542
-2.9%
|
5.73
|
USD 43,216
|
|
2020-10-05 |
2020-10-01 |
B
Purchase
|
Chimovits Erez
Non-Executive Director
Large shareholder
|
296,296
+inf%
6.00
USD 1,777,776
|
296,296
+inf%
|
6.00
|
USD 1,777,776
|
|
2020-10-05 |
2020-10-01 |
B
Purchase
|
Chimovits Erez
Non-Executive Director
Large shareholder
|
639,212
+18.3%
6.00
USD 3,835,272
|
639,212
+18.3%
|
6.00
|
USD 3,835,272
|
|
2020-10-05 |
2020-10-01 |
B
Purchase
|
ORBIMED ADVISORS LLC
Non-Executive Director
Large shareholder
|
296,296
+inf%
6.00
USD 1,777,776
|
296,296
+inf%
|
6.00
|
USD 1,777,776
|
|
2020-10-05 |
2020-10-01 |
B
Purchase
|
ORBIMED ADVISORS LLC
Non-Executive Director
Large shareholder
|
639,212
+18.3%
6.00
USD 3,835,272
|
639,212
+18.3%
|
6.00
|
USD 3,835,272
|
|
2020-10-05 |
2020-10-01 |
B
Purchase
|
Chimovits Erez
Non-Executive Director
Large shareholder
|
545,974
+18.3%
6.00
USD 3,275,844
|
545,974
+18.3%
|
6.00
|
USD 3,275,844
|
|
2020-10-05 |
2020-10-01 |
B
Purchase
|
ORBIMED ADVISORS LLC
Non-Executive Director
Large shareholder
|
545,974
+18.3%
6.00
USD 3,275,844
|
545,974
+18.3%
|
6.00
|
USD 3,275,844
|
|
2020-10-05 |
2020-09-28 |
S
Sale
|
Arix Bioscience plc
Large shareholder
|
273,584
-10.3%
7.54
USD 2,061,866
|
273,584
-10.3%
|
7.54
|
USD 2,061,866
|
|
2020-10-05 |
2020-09-25 |
S
Sale
|
Arix Bioscience plc
Large shareholder
|
174,219
-6.2%
7.08
USD 1,232,948
|
174,219
-6.2%
|
7.08
|
USD 1,232,948
|
|
2020-10-05 |
2020-09-24 |
S
Sale
|
Arix Bioscience plc
Large shareholder
|
38,514
-1.3%
7.63
USD 293,823
|
38,514
-1.3%
|
7.63
|
USD 293,823
|
|
2020-10-05 |
2020-08-13 |
S
Sale
|
Arix Bioscience plc
Large shareholder
|
159
-0.0%
8.75
USD 1,391
|
159
-0.0%
|
8.75
|
USD 1,391
|
|
2020-10-05 |
2020-08-12 |
S
Sale
|
Arix Bioscience plc
Large shareholder
|
1,335
-0.0%
8.79
USD 11,735
|
1,335
-0.0%
|
8.79
|
USD 11,735
|
|
2020-10-05 |
2020-07-29 |
S
Sale
|
Arix Bioscience plc
Large shareholder
|
2,709
-0.1%
8.78
USD 23,788
|
2,709
-0.1%
|
8.78
|
USD 23,788
|
|
2020-10-05 |
2020-07-22 |
S
Sale
|
Arix Bioscience plc
Large shareholder
|
22,651
-0.8%
9.00
USD 203,950
|
22,651
-0.8%
|
9.00
|
USD 203,950
|
|
2020-10-05 |
2020-07-20 |
S
Sale
|
Arix Bioscience plc
Large shareholder
|
36,983
-1.3%
9.25
USD 342,056
|
36,983
-1.3%
|
9.25
|
USD 342,056
|
|
2020-10-05 |
2020-07-17 |
S
Sale
|
Arix Bioscience plc
Large shareholder
|
31,101
-1.0%
9.24
USD 287,373
|
31,101
-1.0%
|
9.24
|
USD 287,373
|
|
2020-10-05 |
2020-07-16 |
S
Sale
|
Arix Bioscience plc
Large shareholder
|
16,332
-0.5%
8.56
USD 139,786
|
16,332
-0.5%
|
8.56
|
USD 139,786
|
|
2018-10-26 |
2018-10-23 |
B
Purchase
|
Arix Bioscience plc
Large shareholder
|
700,000
+30.7%
10.00
USD 7,000,000
|
700,000
+30.7%
|
10.00
|
USD 7,000,000
|
|
2018-10-25 |
2018-10-23 |
B
Purchase
|
Chimovits Erez
Non-Executive Director
|
490,000
+16.3%
10.00
USD 4,900,000
|
490,000
+16.3%
|
10.00
|
USD 4,900,000
|
|
2018-10-25 |
2018-10-23 |
B
Purchase
|
Ioannidou Sofia
Non-Executive Director
|
420,000
+30.7%
10.00
USD 4,200,000
|
420,000
+30.7%
|
10.00
|
USD 4,200,000
|
|
2018-10-25 |
2018-10-23 |
B
Purchase
|
Kariv Tomer
Non-Executive Director
|
100,849
+6.0%
10.00
USD 1,008,490
|
100,849
+6.0%
|
10.00
|
USD 1,008,490
|
|
2018-10-25 |
2018-10-23 |
B
Purchase
|
Kariv Tomer
Non-Executive Director
|
112,000
+7.1%
10.00
USD 1,120,000
|
112,000
+7.1%
|
10.00
|
USD 1,120,000
|
|
2018-10-25 |
2018-10-23 |
B
Purchase
|
Kariv Tomer
Non-Executive Director
|
207,151
+15.1%
10.00
USD 2,071,510
|
207,151
+15.1%
|
10.00
|
USD 2,071,510
|
|
2018-10-25 |
2018-10-23 |
B
Purchase
|
O'Connell Daniel P
Non-Executive Director
|
700,000
+30.7%
10.00
USD 7,000,000
|
700,000
+30.7%
|
10.00
|
USD 7,000,000
|
|
2018-10-25 |
2018-10-23 |
B
Purchase
|
ORBIMED ADVISORS LLC
Non-Executive Director
Large shareholder
|
700,000
+12.1%
10.00
USD 7,000,000
|
700,000
+12.1%
|
10.00
|
USD 7,000,000
|
|
2018-10-25 |
2018-10-23 |
B
Purchase
|
ORBIMED ADVISORS LLC
Non-Executive Director
Large shareholder
|
490,000
+9.3%
10.00
USD 4,900,000
|
490,000
+9.3%
|
10.00
|
USD 4,900,000
|
|